 

  ### Amyloidosis Center

- [Contact Us](#contact-us)
- [Our Multidisciplinary Approach](#our-multidisciplinary-approach)
- [Our Team](#our-team)
- [Research Overview](#research-overview)
 
   ## Contact Us

 [ 830 Harrison Ave., Boston, MA 02118   
3rd Floor   
BMC, Moakley Building ](https://www.google.com/maps/dir/830+Harrison+Avenue,+Boston,+MA+02118) 

 [617.358.4750](tel:617.358.4750) 

Monday – Friday, 8 a.m. to 5 p.m.

 

 

 [    ![](https://assets.bmc.org/transform/5c43790c-e43c-434b-b828-604e66749757/DSALAFIA_A82X2811?io=transform:fill,width:300,height:200&format=jpg)  

 ](/content/moakley-building) 

 



 

  ## Our Multidisciplinary Approach

Boston Medical Center (BMC) is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. This can occur as part of a bone marrow plasma cell disorder (AL), as a hereditary form (AF), an age-related form (senile systemic amyloidosis due to ATTR), or secondary to chronic inflammatory or infectious diseases (AA).

In conjunction with the Boston University Chobanian &amp; Avedisian School of Medicine, the Amyloidosis Center at BMC offers a multidisciplinary approach to diagnosis and treatment of this multi-organ disorder. Under the direction of [Vaishali Sanchorawala, MD](/about-us/directory/doctor/vaishali-sanchorawala-md "Vaishali Sanchorawala, MD | Boston Medical Center (bmc.org)"), the Center is unique in its approach, providing exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research.

Because the disease frequently involves more than one organ system, BMC offers a multispecialty evaluation for patients. This three-day outpatient evaluation is comprised of tests and consultations that help determine the amyloid type and organ system involvement. Patients are guided through each step of the evaluation, with doctors and nurses explaining why each test is being done and what the results mean. Once the evaluation is complete, a treatment plan is developed.

Specialists in [hematology-oncology](/cancer-center/hematology "Cancer Center: What Is Hematology? | Boston Medical Center (bmc.org)"), [cardiovascular medicine](/departments/cardiovascular-center "Cardiovascular Center | Boston Medical Center (bmc.org)"), [gastroenterology](/departments/gastroenterology "Department of Gastroenterology | Boston Medical Center (bmc.org)"), [kidney (renal) medicine](/departments/kidney-medicine "Department of Kidney (Renal) Medicine | Boston Medical Center (bmc.org)"), [neurology](/departments/neurology "Department of Neurology | Boston Medical Center (bmc.org)"), [otolaryngology](/departments/ear-nose-and-throat-otolaryngology "Department of Ear, Nose, and Throat (Otolaryngology) | Boston Medical Center (bmc.org)"), [pathology and laboratory medicine](/medical-professionals/pathology-laboratory-medicine "For Medical Professionals: Pathology & Laboratory Medicine | Boston Medical Center (bmc.org)"), [pulmonary medicine](/departments/pulmonology "Department of Pulmonary, Allergy, Sleep, and Critical Care Medicine (Pulmonology) | Boston Medical Center (bmc.org)"), [radiation oncology](/cancer-center/radiation-oncology "Cancer Center: What Is Radiation Oncology? | Boston Medical Center (bmc.org)"), and [urology](/departments/urology "Department of Urology | Boston Medical Center (bmc.org)") coordinate to evaluate patients and develop care plans.

Medical and pathological consultation services are also available to patients and doctors.

Please visit BU’s Amyloidosis Center website for more information about the different types of amyloidosis, the patient evaluation process, and consultation services.

[Explore the BU Amyloidosis Center](http://www.bu.edu/amyloid/ "Amyloidosis Center | Boston University Chobanian & Avedisian School of Medicine (bu.edu)")



  ## Our Team

The BMC amyloidosis clinical team is a multidisciplinary group of physicians. Each sub-specialist is an amyloid expert and has seen hundreds of patients with amyloidosis.



 

 ###  [Vaishali Sanchorawala, MD](https://www.bmc.org/about-us/directory/doctor/vaishali-sanchorawala-md) 

 Hematologist; Director, Amyloidosis Center 


 

    ![](https://assets.bmc.org/transform/da72392f-69ee-4304-93b8-686910003efb/Vaishali-Sanchorawala_web?io=transform:fill,width:333,height:500&format=jpg)   ###  [John L. Berk, MD](https://www.bmc.org/about-us/directory/doctor/john-l-berk-md) 

 Pulmonologist, Assistant Director, Amyloidosis Center 


 

    ![](https://assets.bmc.org/transform/debe62f7-f31b-45c4-82e0-44494ab36fe8/John-Berk_176_2x3?io=transform:fill,width:333,height:500&format=jpg)   ###  [Sonia Ananthakrishnan, MD](https://www.bmc.org/about-us/directory/doctor/sonia-ananthakrishnan-md) 

 Endocrinologist 


 

    ![](https://assets.bmc.org/transform/aca251f2-a509-489b-b177-2857f2744b14/Sonia-Ananthakrishnanj_web?io=transform:fill,width:333,height:500&format=jpg)   ###  [Eric J. Burks, MD](https://www.bmc.org/about-us/directory/doctor/eric-j-burks-md) 

 Attending Pathologist; Medical Director, Hematopathology and Immunohistochemistry 


 

    ![](https://assets.bmc.org/transform/0c40c935-e3b0-48ba-9c7b-6e1559c91843/Eric-J-Burks-MD_234_2x3?io=transform:fill,width:333,height:500&format=jpg)   ###  [Andrea I. Havasi, MD](https://www.bmc.org/about-us/directory/doctor/andrea-i-havasi-md) 

 Nephrologist 


 

    ![](https://assets.bmc.org/transform/ad864995-2bf1-44a6-91cb-8a04ae3be55b/Andrea-Havasi2828?io=transform:fill,width:333,height:500&format=jpg)   ###  [Shabatun J. Islam, MD](https://www.bmc.org/about-us/directory/doctor/shabatun-j-islam-md) 

 Cardiologist 


 

   ![Placeholder image for doctor](/themes/custom/bmc_base_theme/assets/images/placeholders/headshoticon-v2.svg)  ###  [Kwan Hon Vincent Lau, MD](https://www.bmc.org/about-us/directory/doctor/kwan-hon-vincent-lau-md) 

 Neurologist 


 

    ![](https://assets.bmc.org/transform/b8e1dc53-90c4-4395-a33b-7dde783c3797/Lau_Kwan-Hon-Vincent_MD_Neuro?io=transform:fill,width:333,height:500&format=jpg)   ###  [Caryn A. Libbey, MD](https://www.bmc.org/about-us/directory/doctor/caryn-libbey-md) 

 Rheumatologist 


 

    ![](https://assets.bmc.org/transform/976c2f5d-ea58-42b2-9292-9a43a66e951b/Libbey-Caryn?io=transform:fill,width:333,height:500&format=jpg)   ###  [Lisa M Mendelson, NP](https://www.bmc.org/about-us/directory/doctor/lisa-m-mendelson-np) 

 

 

    ![](https://assets.bmc.org/transform/d27440ea-5724-4126-9295-8dc5447d96b9/Lisa-Mendelson?io=transform:fill,width:333,height:500&format=jpg)   ###  [Hanni Menn-Josephy, MD](https://www.bmc.org/about-us/directory/doctor/hanna-menn-josephy-md) 

 Nephrologist 


 

    ![](https://assets.bmc.org/transform/d6ad588b-7583-42c9-b71f-0146a1332ea1/Josephy-Hanni-Menn?io=transform:fill,width:333,height:500&format=jpg)   ###  [Frederick L. Ruberg, MD](https://www.bmc.org/about-us/directory/doctor/frederick-l-ruberg-md) 

 Chief of Cardiovascular Medicine 


 

    ![Washington, DC - ACC22:  Below is your complimentary Profile Photo that you can use in any way you see fit. Update your ACC Profile or feel free to share with friends and tag your photo #ACC22. You are granted unlimited use for any purpose you need. Todd Buchanan/MedMeetingImages.com 2021](https://assets.bmc.org/transform/5082c9bc-ab0c-47e5-8384-e6f3126f8b0c/Fredrick-Ruberg?io=transform:fill,width:333,height:500&format=jpg)   ###  [Omar K. Siddiqi, MD](https://www.bmc.org/about-us/directory/doctor/omar-k-siddiqi-md) 

 Cardiologist; Director, Cardiovascular Medicine Fellowship Program 


 

    ![](https://assets.bmc.org/transform/ac2b5aa2-fbf8-47b6-8a90-7041e49dff5f/Omar-Siddiqi-MD_763_2x3?io=transform:fill,width:333,height:500&format=jpg)   ###  [J. Mark Sloan, MD](https://www.bmc.org/about-us/directory/doctor/john-m-sloan-md) 

 Hematologist 


 

    ![](https://assets.bmc.org/transform/a9e27b26-e512-413a-863c-82b7492840f2/Mark-J-Sloan?io=transform:fill,width:333,height:500&format=jpg)   

 

 

 



 

  ## Research Overview

Patients with amyloidosis have been immeasurably aided through advances derived from laboratory and translational research programs coordinated by clinical investigators at BMC and laboratory investigators at Boston University Chobanian &amp; Avedisian School of Medicine. The [Amyloidosis Center at the Boston University Chobanian &amp; Avedisian School of Medicine](https://www.bu.edu/amyloid/ "Amyloidosis Center | Boston University Chobanian & Avedisian School of Medicine (bu.edu)") has been in existence since 1960, and has been responsible for many advances in the field, including some of the first randomized treatment trials, stem-cell transplant trials, trials with novel agents and small molecules, and protocols for liver and heart transplantation for selected patients.

[Learn More about Our Research](https://www.bu.edu/amyloid/ "Amyloidosis Center | Boston University Chobanian & Avedisian School of Medicine (bu.edu)")